SEC Filings

SEC Filings

Filing date	Form	Description	Filing Group	Issuer	View
Nov 12, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	Mirum Pharmaceuticals, Inc.	0001564590-20-053195.pdf 0001564590-20-053195.rtf 0001564590-20-053195.xls View HTML
Nov 12, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	Mirum Pharmaceuticals, Inc.	0001564590-20-053201.pdf 0001564590-20-053201.rtf 0001564590-20-053201.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Nov 12, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-20-058024.pdf 0001209191-20-058024.rtf 0001209191-20-058024.xls View HTML
Nov 12, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-20-058035.pdf 0001209191-20-058035.rtf 0001209191-20-058035.xls View HTML
Nov 12, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-20-058048.pdf 0001209191-20-058048.rtf 0001209191-20-058048.xls View HTML
Nov 12, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-20-058044.pdf 0001209191-20-058044.rtf 0001209191-20-058044.xls View HTML
Nov 12, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-20-058052.pdf 0001209191-20-058052.rtf 0001209191-20-058052.xls View HTML
Nov 12, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-20-058054.pdf 0001209191-20-058054.rtf 0001209191-20-058054.xls View HTML
Nov 03, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-20-056690.pdf 0001209191-20-056690.rtf 0001209191-20-056690.xls View HTML
Aug 12, 2020	EFFECT	EFFECT	Other	Mirum Pharmaceuticals, Inc.	9999999995-20-002122.xls View HTML

Data provided by Kaleidoscope.